Market News AIOpen the app

MAZE stock news · Maze Therapeutics Inc

Stories about Maze Therapeutics Inc (MAZE) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for MAZE

Follow Maze Therapeutics Inc (MAZE) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for MAZE
Free on the App Store and Google Play, or on the web.
  1. Sep 23, 2026, 10:10 AM ET · Market

    TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine, and other big stocks climbed on Wednesday.

    Good for MAZE

    Maze Therapeutics had an analyst reaffirm an Outperform rating and keep a $48 price target, which signals continuing analyst confidence in the company.

  2. Aug 17, 2026, 6:15 PM ET · New boss

    Maze Therapeutics, Inc. details leadership transitions including the exit and election of directors, along with the appointment of new officers and their compensation arrangements (MAZE).

    Neutral

    Maze Therapeutics has filed a Form 8-K detailing significant changes in its leadership, including the departure and appointment of certain officers and directors. Such changes can lead to shifts in company strategy and may influence investor sentiment, making it a critical update for stakeholders.